Emil Christensen

3.7k total citations
21 papers, 1.1k citations indexed

About

Emil Christensen is a scholar working on Surgery, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emil Christensen has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 10 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emil Christensen's work include Bladder and Urothelial Cancer Treatments (14 papers), Cancer Genomics and Diagnostics (9 papers) and Renal cell carcinoma treatment (6 papers). Emil Christensen is often cited by papers focused on Bladder and Urothelial Cancer Treatments (14 papers), Cancer Genomics and Diagnostics (9 papers) and Renal cell carcinoma treatment (6 papers). Emil Christensen collaborates with scholars based in Denmark, United States and Netherlands. Emil Christensen's co-authors include Lars Dyrskjøt, Karin Birkenkamp‐Demtröder, Jørgen Bjerggaard Jensen, Iver Nordentoft, Mads Agerbæk, S. Høyer, Torben F. Ørntoft, Philippe Lamy, Michael Knudsen and Thomas Reinert and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Emil Christensen

19 papers receiving 1.1k citations

Peers

Countries citing papers authored by Emil Christensen

Since Specialization

Citations

This map shows the geographic impact of Emil Christensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil Christensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil Christensen more than expected).

Fields of papers citing papers by Emil Christensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emil Christensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil Christensen. The network helps show where Emil Christensen may publish in the future.

Co-authorship network of co-authors of Emil Christensen

This figure shows the co-authorship network connecting the top 25 collaborators of Emil Christensen. A scholar is included among the top collaborators of Emil Christensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emil Christensen. Emil Christensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer 2023 ·Clinical Cancer Research ·Emil Christensen, Iver Nordentoft, Karin Birkenkamp‐Demtröder, (unknown), Sia V. Lindskrog, Ann Taber, (unknown), Trine Strandgaard, Michael Knudsen, Philippe Lamy, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt	36
2	Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up 2023 ·Clinical Cancer Research ·Sia V. Lindskrog, Karin Birkenkamp‐Demtröder, Iver Nordentoft, George Laliotis, Philippe Lamy, Emil Christensen, Derrick Renner, (unknown), (unknown), Shruti Sharma, Adam C. ElNaggar, Minetta C. Liu, Himanshu Sethi, Alexey Aleshin, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt	26
3	Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer 2023 ·European Urology ·Trine Strandgaard, Iver Nordentoft, Karin Birkenkamp‐Demtröder, (unknown), Frederik Prip, (unknown), (unknown), Sia V. Lindskrog, Emil Christensen, Philippe Lamy, Michael Knudsen, Torben Steiniche, Jørgen Bjerggaard Jensen, Lars Dyrskjøt	21
4	Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non–muscle-invasive Bladder Cancer 2022 ·European Urology ·Trine Strandgaard, Sia V. Lindskrog, Iver Nordentoft, Emil Christensen, Karin Birkenkamp‐Demtröder, (unknown), Philippe Lamy, (unknown), Daniel Ranti, (unknown), (unknown), Frederik Prip, (unknown), Torben Steiniche, Nicolai J. Birkbak, John P. Sfakianos, Amir Horowitz, Jørgen Bjerggaard Jensen, Lars Dyrskjøt	39
5	IBCN Seminar Series 2021: Circulating tumor DNA in bladder cancer 2022 ·Urologic Oncology Seminars and Original Investigations ·Emil Christensen, Alexander W. Wyatt, Matthew D. Galsky, Petros Grivas, Roland Seiler, Roman Nawroth, Peter J. Goebell, Bernd J. Schmitz‐Dräger, Stephen B. Williams, Peter C. Black, Ashish M. Kamat, Tilman Todenhöfer, Lars Dyrskjøt	2
6	SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer 2021 ·European Urology Open Science ·(unknown), Philippe Lamy, Sia V. Lindskrog, Emil Christensen, Iver Nordentoft, Karin Birkenkamp‐Demtröder, Benedicte Parm Ulhøi, Jørgen Bjerggaard Jensen, Lars Dyrskjøt	0
7	Mutational Analysis of Field Cancerization in Bladder Cancer 2020 ·Bladder Cancer ·Trine Strandgaard, Iver Nordentoft, Philippe Lamy, Emil Christensen, Mathilde Borg Houlberg Thomsen, Jørgen Bjerggaard Jensen, Lars Dyrskjøt	10
8	Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes 2020 ·Nature Reviews Urology ·Joshua J. Meeks, Hikmat Al‐Ahmadie, Bishoy M. Faltas, John A. Taylor, Thomas W. Flaig, David J. DeGraff, Emil Christensen, Benjamin L. Woolbright, David J. McConkey, Lars Dyrskjøt	121
9	Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis 2020 ·Nature Communications ·Ann Taber, Emil Christensen, Philippe Lamy, Iver Nordentoft, Frederik Prip, Sia V. Lindskrog, Karin Birkenkamp‐Demtröder, Trine Line Hauge Okholm, Michael Knudsen, Jakob Skou Pedersen, Torben Steiniche, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt	135
10	The effect of surgical trauma on circulating free DNA levels in cancer patients—implications for studies of circulating tumor DNA 2020 ·Molecular Oncology ·Tenna Vesterman Henriksen, Thomas Reinert, Emil Christensen, Himanshu Sethi, Karin Birkenkamp‐Demtröder, Mikail Gögenur, Ismail Gögenür, Bernhard Zimmermann, (unknown), Lars Dyrskjøt, Claus L. Andersen	110
11	Molecular Correlates of Cisplatin-based Chemotherapy Response in Muscle Invasive Bladder Cancer by Integrated Multi-omics Analysis 2020 ·Urologic Oncology Seminars and Original Investigations ·Ann Taber, Emil Christensen, Philippe Lamy, Iver Nordentoft, (unknown), (unknown), Karin Birkenkamp‐Demtröder, (unknown), Michael Knudsen, (unknown), Torben Steiniche, Mads Agerbæk, (unknown), Lars Dyrskjøt	0
12	Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients 2018 ·Scientific Reports ·Emil Christensen, Iver Nordentoft, Søren Vang, Karin Birkenkamp‐Demtröder, Jørgen Bjerggaard Jensen, Mads Agerbæk, Jakob Skou Pedersen, Lars Dyrskjøt	46
13	Serial circulating tumor DNA analysis for detection of residual disease, assessment of adjuvant therapy efficacy and for early recurrence detection in colorectal cancer 2018 ·Annals of Oncology ·Thomas Reinert, Tenna Vesterman Henriksen, Mads H. Rasmussen, Himanshu Sethi, Raheleh Salari, (unknown), Ryan Swenerton, Huaqing Wu, (unknown), Emil Christensen, Prem Natarajan, Scott Dashner, (unknown), A. Olson, H. Pawar, Bernhard Zimmermann, Lene Hjerrild Iversen, Mogens Rørbæk Madsen, Jonathan B. Lin, Claus L. Andersen	4
14	Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer 2017 ·Scientific Reports ·Anna Katharina Seitz, Lise Lotte Christensen, Emil Christensen, (unknown), Marie S. Ostenfeld, Jakob Hedegaard, Iver Nordentoft, Morten Muhlig Nielsen, Johan Palmfeldt, (unknown), (unknown), Roman Nawroth, Tobias Maurer, Torben F. Ørntoft, Jørgen Bjerggaard Jensen, Christian Kroun Damgaard, Lars Dyrskjøt	100
15	Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer 2017 ·European Urology ·Emil Christensen, Karin Birkenkamp‐Demtröder, Iver Nordentoft, S. Høyer, (unknown), (unknown), Ellen C. Zwarthoff, Mads Agerbæk, Torben F. Ørntoft, Jørgen Bjerggaard Jensen, Lars Dyrskjøt	148
16	Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis 2017 ·European Urology ·Karin Birkenkamp‐Demtröder, Emil Christensen, Iver Nordentoft, Michael Knudsen, Ann Taber, S. Høyer, Philippe Lamy, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt	122
17	Abstract 2752: Liquid biopsy analysis of FGFR3 and PIK3CA hotspot mutations for disease surveillance in bladder cancer 2017 ·Cancer Research ·Emil Christensen, Karin Birkenkamp‐Demtröder, Iver Nordentoft, S. Høyer, (unknown), (unknown), Ellen C. Zwarthoff, Mads Agerbæk, Torben F. Ørntoft, Jørgen Bjerggaard Jensen, Lars Dyrskjøt	2
18	Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer 2016 ·European Urology ·Karin Birkenkamp‐Demtröder, Iver Nordentoft, Emil Christensen, S. Høyer, Thomas Reinert, Søren Vang, Michael Borre, Mads Agerbæk, Jørgen Bjerggaard Jensen, Torben F. Ørntoft, Lars Dyrskjøt	168
19	Controversies in nephrology: renal albumin handling, facts, and artifacts! 2007 ·Kidney International ·Emil Christensen, Henrik Birn, Bengt Rippe, Arvid B. Maunsbach	45
20	[Prediction of bleeding risks and death in cirrhosis based on hemodynamic and metabolic variables. A study of patients with esophageal varices without previous bleeding]. 1995 ·PubMed ·Søren Møller, (unknown), Emil Christensen, Jens H. Henriksen	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact